Clinical Report: Evaluating the Future Effects of AI Support in Virtual Consultations

Overview

This report explores the potential future impacts of AI in virtual consultations for chronic obstructive pulmonary disease (COPD), emphasizing the need for careful implementation to avoid risks such as automation bias and data integrity issues. It highlights the importance of futures thinking in healthcare to prepare for the integration of AI technologies.

Background

The integration of digital health technologies, including AI, is transforming healthcare delivery, particularly in managing chronic conditions like COPD. However, the successful adoption of these technologies faces challenges related to human factors, technical limitations, and regulatory compliance. Understanding the future implications of AI in virtual consultations is crucial for optimizing patient care and ensuring equitable outcomes.

Data Highlights

No numerical or trial data was provided in the source material.

Key Findings

• AI has the potential to assist in remote patient monitoring and virtual assessments in COPD care.
• Risks associated with AI deployment include automation bias, which can lead to overreliance on AI outputs.
• Technical failures and user errors can result in unequal or harmful patient outcomes.
• Legal and ethical ambiguities exist regarding accountability for AI-driven decisions in healthcare.
• Futures thinking methodologies can aid stakeholders in planning for the integration of AI technologies.

Clinical Implications

Healthcare professionals should remain vigilant about the risks associated with AI technologies, ensuring that they complement rather than replace clinical judgment. Adequate training and user-friendly designs are essential to facilitate the adoption of AI tools in virtual consultations.

Conclusion

The future impact of AI in virtual consultations for COPD presents both opportunities and challenges. A proactive approach to planning and implementation is necessary to harness the benefits while mitigating risks.

Related Resources & Content

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD), GOLD 2025 Report
2. npj Digital Medicine, 2026 -- Evaluating the Quality, Safety, and Inequities of an AI Chatbot in Chronic Disease Management
3. Hybrid virtual coaching and telemonitoring in COPD management: The CAir Study
4. The ASCO Post — ASCO20 Virtual Scientific Program: Next-Generation Oncology Highlights
5. Glaucoma Physician — Integrating AI into the Glaucoma Clinic Recommendations
6. Journal of Medical Internet Research (JMIR) — The Use of Speculative Fiction in Future-Focused Health Care Research
7. ASCO20 Virtual Scientific Program: Next-Generation Oncology Highlights
8. Integrating AI into the Glaucoma Clinic Recommendations
9. Global Initiative for
10. Hybrid virtual coaching and telemonitoring in COPD management: The CAi | COPD
11. Predictive machine learning algorithm for COPD exacerbations using a digital inhaler with integrated sensors - PMC